Abstract
This work presented the development of new cross-linked xanthan gum based biodegradable polymeric system, characterization of their properties and investigation in its potential role for controlled delivery of antiviral drug acyclovir (ACV). Xanthan gum hydrogel formulations (FXG1–FXG9) were developed with different ratio of xanthan gum (XG), acrylic acid (AA), hydroxyethylmethacrylate (HEMA) and methylenebis-acrylamide (MBA). The structures of the hydrogels were characterized by fourier transform infrared spectroscopy (FTIR), thermal analysis, powder X-ray diffraction analysis (PXRD) and scanning electron microscopy (SEM). The swelling characteristics and drug release profile of hydrogels were investigated by varying formulation reactants concentration, cross-linking density, pH of the medium and ionic strength. At pH 7.4, the maximum drug release profile observed in formulation FXG3 was 88.51%, while this value approached to 28.07% at pH 1.2 in simulated gastrointestinal fluid period of 24 h study. The results implicated that the developed hydrogels are potential candidate as drug carrier in controlled release formulations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
